Skip to content

Breast reconstruction: Role of Anastomosis site on Volume of lymphedema and Experience

Breast reconstruction: Role of Anastomosis site on Volume of lymphedema and Experience - BRAVE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040236
Enrollment
74
Registered
2026-05-29
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary arm lymphedema following treatment for breast cancer and its prevention in the context of microsurgical breast reconstruction. I97.2

Interventions

Group 1: IMV Group – Anastomosis to the internal mammary artery and vein (internal mammary vessels) – Data collection at 5 time points (preoperative, Day 6, 6/12/24 months postoperative) using validat

Sponsors

Department für Frauengesundheit
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Written informed consent - Completed primary curative treatment for breast cancer (with the exception of ongoing anti-hormonal therapy) - Following unilateral breast-conserving surgery or mastectomy (with or without prior reconstruction) with axillary intervention (sentinel lymph node biopsy [SNB] or axillary lymph node dissection [aLNE]) - Planned microsurgical breast reconstruction using autologous tissue (DIEP or FCI), in which the anastomosis is to be performed on axillary vessels or on the internal mammary artery and vein

Exclusion criteria

Exclusion criteria: - Expected lack of compliance or limited capacity to provide informed consent - Lack of written consent to participate in the study - Planned or ongoing oncological therapy during the observation period due to tumor recurrence (chemotherapy, radiation, or surgical re-intervention) - Pre-existing severe deformities of the affected limb or thorax that limit the standardized performance of measurements

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is the effect of the anatomical location of the anastomosis (axilla vs. internal thoracic artery) on the postoperative quality of life of patients following microsurgical reconstruction, as measured using the validated BREAST-Q questionnaire.

Secondary

MeasureTime frame
1. Subcutaneous tissue changes – sonographic measurement of skin/subcutaneous tissue thickness using a high-frequency linear probe (12–18 MHz) at 4 defined measurement points (back of the hand, forearm, upper arm, lateral chest), on both sides, as a relative ratio to the opposite side. 2. Arm circumference – Circumference measurement with a measuring tape at 4 defined locations (upper arm, forearm, wrist, metacarpus), bilaterally while seated. 3. Postoperative complications and revision surgeries – standardized documentation (dehiscence, infection, seroma, hematoma, liponecrosis, total necrosis) as part of clinical follow-up care.

Countries

Germany

Contacts

Public ContactJannik Kandzi

Department für Frauengesundheit

Jannik.Kandzi@med.uni-tuebingen.de+497071 29 82211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026